# Lingfang Biology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lingfang-biology

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Latest round: Series A (Nov 1, 2021)
- Investors on record: 2

## About

Established in 2020 and based in Shenzhen, China, Lingfang Biology is a pharmaceutical company that provides anti-tumor targeted drugs. The company's R&D team has decades of experience in new drug development.

The company focuses on the research and development of anti-tumor targeted drugs for gastric cancer, liver cancer, pancreatic cancer, and etc. The company has six product lines  and some of its products are in pre-clinical development stage.

Lingfang Biology will put the funding towards to advance the clinical development of the product and expand the product pipeline.

## Funding rounds

- Series A, Nov 1, 2021 — Cowin Capital, Shanghai Zhizhong Private Equity Fund Management

## Investors

- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series A
- Shanghai Zhizhong Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-zhizhong-private-equity-fund-management) — Series A